Neutrophil gelatinase-associated lipocalin (NGAL) is a rapidly emerging biomarker for early detection of acute kidney injury (AKI). The aim of the study is to evaluate the impact of sepsis on serum NGAL in critically ill children, and to investigate whether the presence of sepsis affects the ability of serum NGAL to predict AKI. Sixty eight patients, who met criteria of sepsis and related syndromes, were classified into two groups (septic shock and severe sepsis). They were reclassified regarding who developed AKI into AKI and non-AKI groups. Twenty sex and age matched healthy subjects served as a control group. Serum NGAL was assayed using Enzymelinked Immunosorbent Assay (ELISA), and serum creatinine was measured using kinetic spectrophotometric method. Serum NGAL levels were significantly high in critically ill septic patients compared to healthy controls (median: 100.4ng/ml vs. 47.1 ng/ml, P>0.0001), and were significantly higher in septic shock (median 105.1ng/ml) than in severe sepsis (median 96ng/ml) with P values of 0.005. However, there was no significant difference in the levels of serum NGAL between AKI patients and non-AKI patients (P=0.3). Receiver operating characteristic (ROC) curve analysis of serum NGAL for prediction of AKI in critically ill septic children showed an area under the curve (AUC) was 0.56 (95% C.I. =0.42-0.70) with an optimal cutoff value of 102.5ng/ml, sensitivity=56.2%, specificity 55.6%, PPV =52.9%, NPV =58.8%, and accuracy=55.9%. For serum creatinine, the AUC was 0.97 (95% C.I. =0.94-1.00) with an optimal cutoff value of 0.6 mg/dl, sensitivity= 90.6%, specificity 91.7%, PPV=90.6%, NPV=91.7% and accuracy=91.2%. In conclusion, serum NGAL is raised in critically ill septic children and is a marker of bacterial infection and systemic inflammation. However, in AKI associated with sepsis, serum NGAL is not a specific biomarker for the prediction of AKI and it loses its early predictive property. In such patients, serum creatinine is more specific than serum NGAL.
INTRODUCTION
Acute kidney injury is common in critically ill children admitted to intensive care unit. The etiology of acute kidney injury is multifactorial and the incidence varies between 1 and 41% (Alkandari et al., 2011) and (Krishnamurthy, 2013) probably due to the different definitions used in clinical studies.Sepsis remains a significant risk factor and it is the leading cause acute kidney injury in critically ill children (Shalaby et al., 2014) . There is an association of acute kidney injury with sepsis in 66.7% and 48.2% progress to septic shock (Consuelo et al., 2012) . Unfortunately, Serum Creatinine (the main acute kidney injury biomarker used in the clinical setting) is a late marker of reduced glomerular filtration rate, which limits ability to detect acute kidney injury early and to initiate 102 clinical therapeutic studies. Therefore, Diagnostic specificity and sensitivity of new biomarkers are currently weighed against creatinine-based criteria (Waikar et al., 2009) . Several proteins and biochemical markers emerged as sensitive and specific biomarkers capable of the early detection of acute tubular injury (Devarajan , 2011) . The most famous of these biomarkers is neutrophil gelatinase-associated lipocalin (NGAL). Neutrophil gelatinase-associated lipocalin (NGAL) is a rapidly emerging biomarker for early detection of AKI. Seemingly, NGAL levels in both plasma and urine can be used to detect AKI days before creatinine at least when the time of insult to the kidneys is known, Wagener et al., (2006) . Before introducing NGAL as an early AKI marker in pediatric ICU, it is vital to clarify the effects of infection/ sepsis on serum NGAL in patients with and without AKI. So, the aim of this work is to study the impact of sepsis on the level of serum NGAL in critically ill pediatric patients and to evaluate whether the presence of sepsis affects the ability of serum NGAL to predict AKI.
MATERIALS AND METHODS
This is a prospective observational study that was conducted in Pediatric Intensive Care Unit (PICU) and emergency room in Sohag University hospital, from January 2018 to December 2018. Sixty eight children with septicemia were included in this study. Sepsis was diagnosed according to the definitions of the American College of Chest Physicians/Society of Critical Care Medicine modified specifically for pediatrics. , Goldstein et al., (2005 (1996) . Informed consents to participate in the study were obtained from all subjects' parents. The study was approved by Sohag University Ethical Committees.
Laboratory Methodology: Samples Collection:
Venous blood samples were withdrawn from all subjects on plain bloodcollection tubes. The obtained samples were centrifuged at 3000 xg for 15 minutes, and serum was stored at -20°C until analysis. Samples were thawed and mixed thoroughly just prior to the assay to avoid erroneous results of repeated freeze/thaw cycles, hemolyzed and lipemic samples were avoided. Serum Neutrophil gelatinaseassociated lipocalin (NGAL) was assayed by Enzyme-linked Immunosorbent Assay (ELISA) and serum creatinine was assayed using the enzymatic spectrophotometric method.
Assay of Serum Creatinine:
Serum creatinine levels were measured by using the kinetic spectrophotometric method according to Jaffe´ method without deproteinization, Mazzachi et al., (2000) . This is a compensated method based on manufacturer's instructions (Roche Diagnostics GmbH, Mannheim, Germany).
Assay of Serum NGAL:
Serum NGAL was assayed according to manufacturer's protocol using Human Lipocalin-2/NGAL ELISA kit (BioVendor Laboratory Medicine. Inc., Cat. No. RD191102200R) for the quantitative measurement of human Lipocalin-2/NGAL. The standards, quality controls and samples were incubated in micro titer wells precoated with polyclonal anti-human Lipocalin-2 antibody. Then biotinlabeled polyclonal anti-human Lipocalin-2 antibody was added and incubated with captured Lipocalin-2. After washing away any unbound biotinylated antibody, the streptavidin-HRP conjugate was added. Following a wash to remove any unbound antibody enzyme reagent, the remaining conjugate was allowed to react with the substrate solution (TMB) resulting in yellow color development proportional to the amount of NGAL bound in the initial step. The color development was stopped by addition of acidic solution and the intensity of the color was proportional to the concentration of Lipocalin-2. The absorbance of the resulting yellow color was measured spectrophotometrically at 450 nm. A standard curve was constructed by plotting absorbance values against concentrations of the standards, and concentrations of the samples were determined using this curve, Mori et al., (2007 (Figure 1 &table1) .
Multivariate regression analysis showed that septic shock was the only independent variable for elevation of serum NGAL, P=0.006 (Table 2) . AKI was developed in 32 (47.06%) out of 68 critically ill patients, there was no significant difference in the level of serum NGAL between patients with AKI compared to those without AKI (P=0.3). In consistence with the definition of AKI used in this study, serum creatinine was significantly increased in critically ill children with AKI (P<0.0001) ( Table 3 ). Figure 2 shows the receiver operating characteristic (ROC) curve analysis of serum NGAL and serum creatinine for prediction of AKI in critically ill septic children. For serum NGAL, the area under the curve (AUC) was 0.56 (95% C.I. =0.42-0.70) with an optimal cutoff value of 102.5ng/ml, sensitivity=56.2%, specificity 55.6%, PPV =52.9%, NPV =58.8%, and accuracy=55.9%. For serum creatinine, the AUC was 0.97 (95% C.I. =0.94-1.00) with an optimal cutoff value of 0.6 mg/dl, sensitivity= 90.6%, specificity 91.7%, PPV=90.6%, NPV=91.7% and accuracy=91.2%.
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Figure (2) Comparison between Receiver operating characteristic (ROC) curve analysis of serum NGAL and serum creatinine concentrations for prediction of AKI in cases. (p<0.0001)
Discussion
AKI is common among critically ill children and early diagnosis is vital to prevent and decrease associated morbidity and mortality. Sepsis remains a significant risk factor and it is the leading cause of acute kidney injury in critically ill children (Shalaby et al., 2014) . Neutrophil gelatinase-associated lipocalin (NGAL) is a rapidly emerging biomarker for early detection ofAKI. NGAL is a 25 KDa protein that is expressed at very low concentrations in several human tissues including the kidney, lungs, and gastrointestinal tract, Kjeldsen et al., (2000) . It is released by neutrophils upon activation and it is a marker of bacterial infection and systemic inflammation, Mori et al., (2005) . In this study, we evaluated serum NGAL as a biomarker of sepsis and as a specific predictor for AKI in septic children. We found that, serum NGAL was significantly increased in critically ill children with different grades of sepsis (severe sepsis and septic shock) compared to healthy controls. Also, serum NGAL in critically ill children with septic shock was significantly higher than in critically ill children with severe sepsis, reflecting the severity of illness in those patients. Our results in accordance with Singer E. et al, 2013 who declared that NGAL has important limitations in early detection of AKI, including its responsiveness in systemic inflammation, which is partially uncoupled from its response to kidney injury and which needs to be considered when interpreting NGAL results clinically. The picture in critically ill septic patients was somewhat less clear, since sepsis is an important inducer of blood and urinary (2008) stated that serum NGAL is significantly increased within the first 24 hours and remains increased at day 3 following admission to the pediatric ICU in critically ill children who develop AKI compared to critically ill children who do not develop AKI. They reported a sensitivity=86% and specificity=39% and concluded that serum NGAL is a high sensitive but a non-specific predictor of AKI in critically ill children with septic shock. Zappitelli et al., (2007) hypothesized that sepsis induced a greater ''injury'' to the kidney compared with other contributing factors, and higher plasma NGAL levels have been associated with greater severity of AKI. In our study, ROC analysis showed that serum NGAL had a poor sensitivity with poor specificity for prediction of AKI, and their ability to predict AKI in patients with septic shock was poor with an AUC-ROC =0.56. In accordance to our result, Wheeler et al., (2008) and Martensson et al., (2010) found that the ability of plasma NGAL to predict AKI in patients with septic shock was poor with AUC-ROC (0.68 and 0.67 respectively).Meanwhile, ROC analysis of serum creatinine in our study showed a higher sensitivity and higher specificity for prediction of AKI, so serum creatinine has better ability to predict AKI in septic patients.
Conclusion
We concluded that serum NGAL is raised in critically ill septic children in pediatric ICU and is a marker of bacterial infection and systemic inflammation. However, in AKI associated with sepsis, serum NGAL is not a specific biomarker for the prediction of AKI and it loses its early predictive property. In such patients, serum creatinine is more sensitive and specific than serum NGAL.
